Dr. Steven Coutre on Frontline Treatment Decisions in CLL
October 2nd 2016Steven Coutre, MD, professor of medicine (hematology) at Stanford University Medical Center, discusses considerations when selecting between oral therapies like ibrutinib and chemoimmunotherapy for first-line treatment of chronic lymphocytic leukemia (CLL).
Read More